10 Worldwide prevalence and prevention of hepatitis c

Biomedical Research Reports

Volumn 2, Issue C, 2000, Pages

  Lavanchy, Daniel ^a   McMahon, Brian ^b  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b ALASKA NATIVE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957072693     PISSN: 18745326     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1874-5326(00)80014-9     Document Type: Article

References (82)

1. World Health Report. Geneva: World Health Organization, 1996.
2. World Health Organization. Hepatitis C: global prevalence. Wkly Epidemiol Rec 72 (1997) 341-344
3. World Health Organization. Hepatitis C. Wkly Epidemiol Rec 72 (1997) 65-69
4. World Health Organization. Global surveillance and control of hepatitis C. J Med Virol 6 (1999) 35-47
5. Di Bisceglie A.M., Order S.E., Klein J.L., et al. The role of chronic viral hepatitis in hepatocellular carcinoma in the United States. Am J Gastroenterol 86 3 (1991) 335-338
6. Fattovich G., Giustina G., Degos F., et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 112 2 (1997) 463-472
7. (4 Pt 1). Kiyosawa K., Sodeyama T., Tanaka E., et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 12 (1990) 671-675
8. Seeff L.B., Buskell-Bales Z., Wright E.C., et al. Long-term mortality after transfusion-associated non-A, non-B hepatitis. N Engl J Med 327 27 (1992) 1906-1911
9. Alter H.J., Jett B.W., Polito A.J., et al. Analysis of the role of hepatitis C virus in transfusion-associated hepatitis (1991), Williams & Wilkins, Baltimore, MD
10. Aach R.D., Stevens C.E., Hollinger F.B., et al. Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays. N Engl J Med 325 19 (1991) 1325-1329
11. Koretz R.L., Abbey H., Coleman E., and Gitnick G. Non-A, non-B post-transfusion hepatitis. Looking back in the second decade. Ann Intern Med 119 2 (1993) 110-115
12. Hagan H., McGough J.P., Thiede H., Weiss N.S., Hopkins S., and Alexander E.R. Syringe exchange and risk of infection with hepatitis B and C viruses. Am J Epidemiol 149 3 (1999) 203-213
13. Tanaka H., Tsukuma H., Hori Y., et al. The risk of hepatitis C virus infection among blood donors in Osaka. Japan. J Epidemiol 8 5 (1998) 292-296
14. Broers B., Junet C., Bourquin M., Deglon J.J., Perrin L., and Hirschel B. Prevalence and incidence rate of HIV, hepatitis B and C among drug users on methadone maintenance treatment in Geneva between 1988 and 1995. AIDS 12 15 (1998) 2059-2066
15. van Beek I., Dwyer R., Dore G.J., Luo K., and Kaldor J.M. Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study. BMJ 317 (1998) 433-437
16. Dutta U., Raina V., Garg P.K., et al. A prospective study on the incidence of hepatitis B & C infections amongst patients with lymphoproliferative disorders. Indian J Med Res 107 (1998) 78-82
17. Fabrizi F., Martin P., Dixit V., et al. Acquisition of hepatitis C virus in hemodialysis patients: a prospective study by branched DNA signal amplification assay. Am J Kidney Dis 31 4 (1998) 647-654
18. Crofts N., Jolley D., Kaldor J., van Beek I., and Wodak A. Epidemiology of hepatitis C virus infection among injecting drug users in Australia. J Epidemiol Commun Health 51 6 (1997) 692-697
19. el-Ahmady O., Halim A.B., Mansour O., and Salman T. Incidence of hepatitis C virus in Egyptians. J Hepatol 21 4 (1994) 687
20. Moyer L.A., Mast E.E., and Alter M.J. Hepatitis C: Part I. Routine serologic testing and diagnosis. Am Fam Physician 59 1 (1999) 79-88
21. Moyer L.A., Mast E.E., and Alter M.J. Hepatitis C: Part I. Routine serologic testing and diagnosis. Am Fam Physician 59 1 (1999) 91-92
22. Simmonds P., Alberti A., Alter H.J., et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 19 5 (1994) 1321-1324
23. (Pt 7). Smith D.B., Mellor J., Jarvis L.M., et al. Variation of the hepatitis C virus 5' non-coding region: implications for secondary structure, virus detection and typing. The International HCV Collaborative Study Group. J Gen Virol 76 (1995) 1749-1761
24. 17. Bukh J., Purcell R.H., and Miller R.H. At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide. Proc Natl Acad Sci U S A 90 (1993) 8234-8238
25. McOmish F., Yap P.L., Dow B.C., et al. Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol 32 4 (1994) 884-892
26. (Pt 5). Davidson F., Simmonds P., Ferguson J.C., et al. Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5′ non-coding region. J Gen Virol 76 (1995) 1197-1204
27. Stuyver L., Wyseur A., van Arnhem W., Hernandez F., and Maertens G. Second-generation line probe assay for hepatitis C virus genotyping. J Clin Microbiol 34 9 (1996) 2259-2266
28. (Pt 4). Tokita H., Shrestha S.M., Okamoto H., et al. Hepatitis C virus variants from Nepal with novel genotypes and their classification into the third major group. J Gen Virol 75 (1994) 931-936
29. (Pt 9). Ruggieri A., Argentini C., Kouruma F., et al. Heterogeneity of hepatitis C virus genotype 2 variants in West Central Africa (Guinea Conakry). J Gen Virol 77 (1996) 2073-2076
30. 21. Stuyver L., van Arnhem W., Wyseur A., Hernandez F., Delaporte E., and Maertens G. Classification of hepatitis C viruses based on phylogenetic analysis of the envelope 1 and nonstructural 5B regions and identification of five additional subtypes. Proc Natl Acad Sci U S A 91 (1994) 10134-10138
31. (Pt 10). Mellor J., Holmes E.C., Jarvis L.M., Yap P.L., and Simmonds P. Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. The International HCV Collaborative Study Group. J Gen Virol 76 (1995) 2493-2507
32. (Pt 9). Tokita H., Okamoto H., Luengrojanakul P., et al. Hepatitis C virus variants from Thailand classifiable into five novel genotypes in the sixth (6b), seventh (7c, 7d) and ninth (9b, 9c) major genetic groups. J Gen Virol 76 (1995) 2329-2335
33. Mellor J., Walsh E.A., Prescott L.E., et al. Survey of type 6 group variants of hepatitis C virus in Southeast Asia by using a core-based genotyping assay. J Clin Microbiol 34 2 (1996) 417-423
34. 23. Tokita H., Okamoto H., Tsuda F., et al. Hepatitis C virus variants from Vietnam are classifiable into the seventh, eighth, and ninth major genetic groups. Proc Natl Acad Sci U S A 91 (1994) 11022-11026
35. Bernier L., Willems B., Delage G., and Murphy D.G. Identification of numerous hepatitis C virus genotypes in Montreal, Canada. J Clin Microbiol 34 11 (1996) 2815-2818
36. McCaw R., Moaven L., Locarnini S.A., and Bowden D.S. Hepatitis C virus genotypes in Australia. J Viral Hepatitis 4 5 (1997) 351-357
37. (Pt 7). van Doorn L.J., Kleter G.E., Stuyver L., et al. Sequence analysis of hepatitis C virus genotypes 1 to 5 reverals multiple novel subtypes in the Benelux countries. J Gen Virol 76 (1995) 1871-1876
38. Alter M.J., Hadler S.C., Judson F.N., et al. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA 264 17 (1990) 2231-2235
39. Schreiber G.B., Busch M.P., Kleinman S.H., and Korelitz J.J. The risk of transfusion-transmitted viral infections. N Engl J Med 334 26 (1996) 1685-1690
40. Mansell C.J., and Locarnini S.A. Epidemiology of hepatitis C in the East. Seminars Liver Dis 15 (1995) 15-32
41. Mele A., Sagliocca L., Manzillo G., et al. Risk factors for acute non-A, non-B hepatitis and their relationship to antibodies for hepatitis C virus: a case-control study. Am J Public Health 84 10 (1994) 1640-1643
42. Kiyosawa K., Tanaka E., Sodeyama T., et al. Transmission of hepatitis C in an isolated area in Japan: community-acquired infection. The South Kiso Hepatitis Study Group. Gastroenterology 106 6 (1994) 1596-1602
43. Kaldor J.M., Archer G.T., Buring M.L., et al. Risk factors for hepatitis C virus infection in blood donors: a case-control study. Med J Aust 157 4 (1992) 227-230
44. Tumminelli F., Marcellin P., Rizzo S., et al. Shaving as potential source of hepatitis C virus infection. Lancet 345 (1995) 658
45. Stroffolini T., Menchinelli M., Taliani G., et al. High prevalence of hepatitis C virus infection in a small central Italian town: lack of evidence of parenteral exposure. Ital J Gastroenterol 27 5 (1995) 235-238
46. Mele A., Corona R., Tosti M.E., et al. Beauty treatments and risk of parenterally transmitted hepatitis: results from the hepatitis surveillance system in Italy. Scand J Infect Dis 27 5 (1995) 441-444
47. Sun D.X., Zhang F.G., Geng Y.Q., and Xi D.S. Hepatitis C transmission by cosmetic tattooing in women. Lancet 347 (1996) 541
48. Thomas D.L., Villano S.A., Riester K.A., et al. Perinatal transmission of hepatitis C virus from human immunodeficiency virus type 1-infected mothers. Women and Infants Transmission Study. J Infect Dis 177 6 (1998) 1480-1488
49. Resti M., Azzari C., Lega L., et al. Mother-to-infant transmission of hepatitis C virus. Acta Paediatr 84 3 (1995) 251-255
50. Manzini P., Saracco G., Cerchier A., et al. Human immunodeficiency virus infection as risk factor for mother-to-child hepatitis C virus transmission; persistence of anti-hepatitis C virus in children is associated with the mother's anti-hepatitis C virus immunoblotting pattern. Hepatology 21 2 (1995) 328-332
51. Zanetti A.R., Tanzi E., Paccagnini S., et al. Mother-to-infant transmission of hepatitis C virus. Lombardy Study Group on Vertical HCV Transmission. Lancet 345 (1995) 289-291
52. Paccagnini S., Principi N., Massironi E., et al. Perinatal transmission and manifestation of hepatitis C virus infection in a high risk population. Pediatr Infect Dis J 14 3 (1995) 195-199
53. Lin H.H., Kao J.H., Hsu H.Y., et al. Absence of infection in breast-fed infants born to hepatitis C virus-infected mothers. J Pediatr 126 4 (1995) 589-591
54. Ohto H., Okamoto H., and Mishira S. Vertical transmission of hepatitis C virus. Lancet 331 (1994) 400
55. Arthur R.R., Hassan N.F., Abdallah M.Y., et al. Hepatitis C antibody prevalence in blood donors in different governorates in Egypt. Trans R Soc Trop Med Hyg 91 3 (1997) 271-274
56. Mohamed M.K., Rakhaa M., Shoeir S., and Saber M. Viral hepatitis C infection among Egyptians, the magnitude of the problem: epidemiological and laboratory approach. J Egypt Public Health Assoc 71 1,2 (1996) 79-112
57. el Gohary A., Hassan A., Nooman Z., et al. High prevalence of hepatitis C virus among urban and rural population groups in Egypt. Acta Trop 59 2 (1995) 155-161
58. el-Sayed N.M., Gomatos P.J., Rodier G.R., et al. Seroprevalence survey of Egyptian tourism workers for hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and Treponema pallidum infections: association of hepatitis C virus infections with specific regions of Egypt. Am J Trop Med Hyg 55 2 (1996) 179-184
59. Mohamed M.K., Hussein M.H., Massoud A.A., et al. Study of the risk factors for viral hepatitis C infection among Egyptians applying for work abroad. J Egypt Public Health Assoc 71 1,2 (1996) 113-147
60. Quinti I., el-Salman D., Monier M.K., et al. HCV infection in Egyptian patients with acute hepatitis. Dig Dis Sci 42 10 (1997) 2017-2023
61. Darwish M.A., Raouf T.A., Rushdy P., Constantine N.T., Rao M.R., and Edelman R. Risk factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors. Am J Trop Med Hyg 49 4 (1993) 440-447
62. Farghaly A.G., and Barakat R.M. Prevalence, impact and risk factors of hepatitis C infection. J Egypt Public Health Assoc 68 1-2 (1993) 63-79
63. Quinti I., Renganathan E., El Ghazzawi E., et al. Seroprevalence of HIV and HCV infections in Alexandria, Egypt. Zentralbl Bakteriol 283 2 (1995) 239-244
64. el-Sayed H.F., Abaza S.M., Mehanna S., and Winch P.J. The prevalence of hepatitis B and C infections among immigrants to a newly reclaimed area endemic for Schistosoma mansoni in Sinai, Egypt. Acta Trop 68 2 (1997) 229-237
65. World Health Organization. The control of schistosomiasis, 2nd report ot the WHO expert committee. W H O Tech Rep Ser 930 (1993) 70-71
66. Frank C, Mohamed M, Strickland T, et al. The role of parental antischistosomal therapy in the spread of hepatitis C virus in Egypt. Submitted for publication.
67. Guadagnino V., Stroffolini T., Rapicetta M., et al. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy. Hepatology 26 4 (1997) 1006-1011
68. Okuda K. Hepatitis C virus and hepatocellular carcinoma. In: Okuda K., and Taber E. (Eds). Liver cancer (1997), Churchill-Livingston, New York 39-50
69. Conry-Cantilena C., VanRaden M., Gibble J., et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 334 26 (1996) 1691-1696
70. McMahon B. Hepatocellular carcinoma and viral hepatitis. In: Wilson R.A. (Ed). Viral hepatitis (1997), Dekker, New York 315-329
71. Nishioka K., Watanabe J., Furuta S., et al. A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer 67 2 (1991) 429-433
72. Saito I., Miyamura T., Ohbayashi A., et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci U S A 87 (1990) 6547-6549 17
73. Simonetti R.G., Camma C., Fiorello F., et al. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study. Ann Intern Med 116 2 (1992) 97-102
74. Levrero M., Tagger A., Balsano C., et al. Antibodies to hepatitis C virus in patients with hepatocellular carcinoma. J Hepatol 12 1 (1991) 60-63
75. Tanaka E., Kiyosawa K., Sodeyama T., et al. Prevalence of antibody to hepatitis C virus in Japanese schoolchildren: comparison with adult blood donors. Am J Trop Med Hyg 46 4 (1992) 460-464
76. Okuda K., Fujimoto I., Hanai A., and Urano Y. Changing incidence of hepatocellular carcinoma in Japan. Cancer Res 47 18 (1987) 4967-4972
77. Recommendations for follow-up of health-care workers after occupational exposure to hepatitis C virus. Centers for Disease Control MMWR 46 26 (1997) 603-606
78. Alter M.J. Occupational exposure to hepatitis C virus: a dilemma. Infect Control Hosp Epidemiol 15 12 (1994) 742-744
79. Camma C., Almasio P., and Craxi A. Interferon as treatment for acute hepatitis C. A meta-analysis. Dig Dis Sci 41 6 (1996) 1248-1255
80. Poynard T., Bedossa P., and Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 349 (1997) 825-832
81. Love R.A., Parge H.E., Wickersham J.A., et al. The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site. Cell 87 2 (1996) 331-342
82. Fang J.W.S., Chow V., and Lau J. Virology of hepatitis C virus. Clin Liver Dis 1 (1997) 493-514